Ropivacaine Prevents the Activation of the NLRP3 Inflammasome Caused by High Glucose in HUVECs

Endothelial dysfunction caused by high glucose is recognized as an important event in the pathogenesis of diabetes-related vascular complications. Ropivacaine is considered to have the best safety profile among the commonly used amide local anesthetics, but the extent of its actions remains incomple...

Full description

Saved in:
Bibliographic Details
Published inACS omega Vol. 5; no. 36; pp. 23413 - 23419
Main Authors Huang, Xin, Jiang, Jingyan, Huang, Lijun, Ren, Qiusheng, Gao, Xiang, Yu, Shenghui
Format Journal Article
LanguageEnglish
Published American Chemical Society 15.09.2020
Online AccessGet full text

Cover

Abstract Endothelial dysfunction caused by high glucose is recognized as an important event in the pathogenesis of diabetes-related vascular complications. Ropivacaine is considered to have the best safety profile among the commonly used amide local anesthetics, but the extent of its actions remains incompletely understood. Here, we used human umbilical vein endothelial cells exposed to high glucose to explore the effects of ropivacaine on oxidative stress and markers of inflammation. Ropivacaine treatment exerted significant beneficial effects by rescuing oxidative stress and downregulating interleukin (IL)-1β and IL-18. We also found that ropivacaine could inhibit the secretion of the high-mobility group box 1 protein and improve cell viability. Importantly, sirtuin-1 (SIRT1) knockdown experiments show that the inhibitory effects of ropivacaine against NLRP3 inflammasome activation are dependent on SIRT1. Taken together, these results demonstrate the potential of ropivacaine as a promising therapy against diabetic endothelial dysfunction.
AbstractList Endothelial dysfunction caused by high glucose is recognized as an important event in the pathogenesis of diabetes-related vascular complications. Ropivacaine is considered to have the best safety profile among the commonly used amide local anesthetics, but the extent of its actions remains incompletely understood. Here, we used human umbilical vein endothelial cells exposed to high glucose to explore the effects of ropivacaine on oxidative stress and markers of inflammation. Ropivacaine treatment exerted significant beneficial effects by rescuing oxidative stress and downregulating interleukin (IL)-1β and IL-18. We also found that ropivacaine could inhibit the secretion of the high-mobility group box 1 protein and improve cell viability. Importantly, sirtuin-1 (SIRT1) knockdown experiments show that the inhibitory effects of ropivacaine against NLRP3 inflammasome activation are dependent on SIRT1. Taken together, these results demonstrate the potential of ropivacaine as a promising therapy against diabetic endothelial dysfunction.
Endothelial dysfunction caused by high glucose is recognized as an important event in the pathogenesis of diabetes-related vascular complications. Ropivacaine is considered to have the best safety profile among the commonly used amide local anesthetics, but the extent of its actions remains incompletely understood. Here, we used human umbilical vein endothelial cells exposed to high glucose to explore the effects of ropivacaine on oxidative stress and markers of inflammation. Ropivacaine treatment exerted significant beneficial effects by rescuing oxidative stress and downregulating interleukin (IL)-1β and IL-18. We also found that ropivacaine could inhibit the secretion of the high-mobility group box 1 protein and improve cell viability. Importantly, sirtuin-1 (SIRT1) knockdown experiments show that the inhibitory effects of ropivacaine against NLRP3 inflammasome activation are dependent on SIRT1. Taken together, these results demonstrate the potential of ropivacaine as a promising therapy against diabetic endothelial dysfunction.
Author Huang, Xin
Ren, Qiusheng
Jiang, Jingyan
Huang, Lijun
Yu, Shenghui
Gao, Xiang
AuthorAffiliation The Affiliated People’s Hospital of Ningbo University
Department of Anesthesiology
AuthorAffiliation_xml – name: Department of Anesthesiology
– name: The Affiliated People’s Hospital of Ningbo University
Author_xml – sequence: 1
  givenname: Xin
  orcidid: 0000-0001-9376-8497
  surname: Huang
  fullname: Huang, Xin
  email: Huangxin1784@163.com
– sequence: 2
  givenname: Jingyan
  surname: Jiang
  fullname: Jiang, Jingyan
– sequence: 3
  givenname: Lijun
  surname: Huang
  fullname: Huang, Lijun
– sequence: 4
  givenname: Qiusheng
  surname: Ren
  fullname: Ren, Qiusheng
– sequence: 5
  givenname: Xiang
  surname: Gao
  fullname: Gao, Xiang
– sequence: 6
  givenname: Shenghui
  surname: Yu
  fullname: Yu, Shenghui
BookMark eNp1kc1vEzEQxS1UREvpnaOPHEjrr12vL0hVVJpIUakqyhHLa48TR7t2sHcj9b9n2wRED5xszXvze9K89-gkpggIfaTkkhJGr4wtqYe1uSSWcCr4G3TGhCQzygU_-ed_ii5K2RJCaN2whtXv0ClnqhJUiTP08yHtwt5YEyLg-wx7iEPBwwbwtR0mYQgp4uRfJnerh3uOl9F3pu_Ncziem7GAw-0TXoT1Bt92o00FcIh48fjjZl4-oLfedAUuju85evx6832-mK2-3S7n16uZEbIeZsq3VkolW8MMY8ozaEGSlhPLvK3aird1zYnhzhlWO7DcVs630oEnDVfC83O0PHBdMlu9y6E3-UknE_TLIOW1NnkItgPtHJfSe8mcqEVDQXHGq6ahtqJTECET68uBtRvbHpydLpJN9wr6Wolho9dpr6VQNWHNBPh0BOT0a4Qy6D4UC11nIqSxaCaEqEmlpJis5GC1OZWSwf-NoUQ_t6z_tKyPLU8rnw8rk6K3acxxOuz_7b8Bz0qroA
CitedBy_id crossref_primary_10_1096_fj_202100067R
crossref_primary_10_3892_etm_2022_11486
Cites_doi 10.1124/jpet.116.232934
10.1016/j.phrs.2015.05.012
10.1016/j.vph.2016.12.002
10.1097/aln.0000000000000174
10.3389/fphys.2015.00093
10.1016/j.it.2011.01.003
10.5812/aapm.85704
10.2344/0003-3006-59.2.90
10.1007/s00125-013-3115-6
10.1155/2015/848272
10.4103/0019-5049.135040
10.1038/pr.2012.24
10.1002/jcb.28006
10.1016/j.bbrc.2016.11.017
10.1159/000470822
10.1016/j.bjoms.2013.08.014
10.1016/j.jdiacomp.2015.12.018
10.1371/journal.pone.0036949
10.1016/j.yjmcc.2007.08.008
10.1038/s41419-018-0764-x
10.1016/j.molimm.2018.07.008
10.1055/s-0038-1675498
10.2337/dc16-2736
10.1159/000496425
10.1038/sj.bjp.0703393
10.1002/pmrj.12007
10.1007/s10557-013-6498-1
10.1074/jbc.m112.419101
10.1016/j.imbio.2016.11.002
10.1155/2019/5647219
10.1161/01.res.0000022161.42655.98
10.1002/jcp.21852
10.1016/j.gene.2018.07.063
ContentType Journal Article
Copyright Copyright © 2020 American Chemical Society 2020 American Chemical Society
Copyright_xml – notice: Copyright © 2020 American Chemical Society 2020 American Chemical Society
DBID N~.
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1021/acsomega.0c03143
DatabaseName American Chemical Society (ACS) Open Access
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

Database_xml – sequence: 1
  dbid: N~.
  name: American Chemical Society (ACS) Open Access
  url: https://pubs.acs.org
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2470-1343
EndPage 23419
ExternalDocumentID oai_doaj_org_article_dd377ff72d46481e93235881c51b5300
10_1021_acsomega_0c03143
h48175788
GroupedDBID 53G
ABUCX
ACS
ADACO
ADBBV
AFEFF
ALMA_UNASSIGNED_HOLDINGS
BCNDV
EBS
GROUPED_DOAJ
HYE
N~.
OK1
RPM
VF5
AAFWJ
AAHBH
AAYXX
AFPKN
AOIJS
CITATION
M~E
7X8
5PM
ID FETCH-LOGICAL-a476t-9fbc7797ba2a229f2ebe70b30c2fc5b53b6630a3dda26dec3c5dfb7def08394f3
IEDL.DBID RPM
ISSN 2470-1343
IngestDate Tue Oct 22 15:14:58 EDT 2024
Tue Sep 17 21:08:58 EDT 2024
Fri Aug 16 06:23:53 EDT 2024
Fri Aug 23 03:38:53 EDT 2024
Thu Sep 17 03:19:00 EDT 2020
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 36
Language English
License This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a476t-9fbc7797ba2a229f2ebe70b30c2fc5b53b6630a3dda26dec3c5dfb7def08394f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9376-8497
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496028/
PMID 32954194
PQID 2444605974
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_dd377ff72d46481e93235881c51b5300
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7496028
proquest_miscellaneous_2444605974
crossref_primary_10_1021_acsomega_0c03143
acs_journals_10_1021_acsomega_0c03143
ProviderPackageCode ACS
ABUCX
AFEFF
VF5
N~.
PublicationCentury 2000
PublicationDate 2020-09-15
PublicationDateYYYYMMDD 2020-09-15
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-15
  day: 15
PublicationDecade 2020
PublicationTitle ACS omega
PublicationTitleAlternate ACS Omega
PublicationYear 2020
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref6/cit6
ref3/cit3
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
ref32/cit32
ref23/cit23
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref34/cit34
ref28/cit28
ref20/cit20
ref17/cit17
ref10/cit10
ref35/cit35
ref19/cit19
Suchanek H. (ref27/cit27) 2005; 16
ref21/cit21
ref12/cit12
ref15/cit15
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
Cosentino F. (ref26/cit26) 1998; 32
ref30/cit30
ref1/cit1
ref24/cit24
ref7/cit7
References_xml – ident: ref9/cit9
  doi: 10.1124/jpet.116.232934
– ident: ref35/cit35
  doi: 10.1016/j.phrs.2015.05.012
– ident: ref29/cit29
  doi: 10.1016/j.vph.2016.12.002
– ident: ref31/cit31
  doi: 10.1097/aln.0000000000000174
– ident: ref32/cit32
  doi: 10.3389/fphys.2015.00093
– ident: ref11/cit11
  doi: 10.1016/j.it.2011.01.003
– ident: ref19/cit19
  doi: 10.5812/aapm.85704
– ident: ref17/cit17
  doi: 10.2344/0003-3006-59.2.90
– ident: ref16/cit16
  doi: 10.1007/s00125-013-3115-6
– volume: 32
  start-page: S54
  year: 1998
  ident: ref26/cit26
  publication-title: J. Cardiovasc. Pharmacol.
  contributor:
    fullname: Cosentino F.
– ident: ref2/cit2
  doi: 10.1155/2015/848272
– ident: ref24/cit24
  doi: 10.4103/0019-5049.135040
– ident: ref12/cit12
  doi: 10.1038/pr.2012.24
– ident: ref6/cit6
  doi: 10.1002/jcb.28006
– ident: ref23/cit23
  doi: 10.1016/j.bbrc.2016.11.017
– ident: ref14/cit14
  doi: 10.1159/000470822
– ident: ref25/cit25
  doi: 10.1016/j.bjoms.2013.08.014
– ident: ref3/cit3
  doi: 10.1016/j.jdiacomp.2015.12.018
– ident: ref28/cit28
  doi: 10.1371/journal.pone.0036949
– ident: ref21/cit21
  doi: 10.1016/j.yjmcc.2007.08.008
– ident: ref10/cit10
  doi: 10.1038/s41419-018-0764-x
– ident: ref13/cit13
  doi: 10.1016/j.molimm.2018.07.008
– ident: ref30/cit30
  doi: 10.1055/s-0038-1675498
– ident: ref1/cit1
  doi: 10.2337/dc16-2736
– volume: 16
  start-page: 177
  year: 2005
  ident: ref27/cit27
  publication-title: Eur. Cytokine Network
  contributor:
    fullname: Suchanek H.
– ident: ref20/cit20
  doi: 10.1159/000496425
– ident: ref5/cit5
  doi: 10.1038/sj.bjp.0703393
– ident: ref18/cit18
  doi: 10.1002/pmrj.12007
– ident: ref15/cit15
  doi: 10.1007/s10557-013-6498-1
– ident: ref8/cit8
  doi: 10.1074/jbc.m112.419101
– ident: ref22/cit22
  doi: 10.1016/j.imbio.2016.11.002
– ident: ref7/cit7
  doi: 10.1155/2019/5647219
– ident: ref4/cit4
  doi: 10.1161/01.res.0000022161.42655.98
– ident: ref33/cit33
  doi: 10.1002/jcp.21852
– ident: ref34/cit34
  doi: 10.1016/j.gene.2018.07.063
SSID ssj0001682826
Score 2.189021
Snippet Endothelial dysfunction caused by high glucose is recognized as an important event in the pathogenesis of diabetes-related vascular complications. Ropivacaine...
Endothelial dysfunction caused by high glucose is recognized as an important event in the pathogenesis of diabetes-related vascular complications. Ropivacaine...
SourceID doaj
pubmedcentral
proquest
crossref
acs
SourceType Open Website
Open Access Repository
Aggregation Database
Publisher
StartPage 23413
SummonAdditionalLinks – databaseName: American Chemical Society Journals
  dbid: ACS
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELWgHMqlhbao2wIyUnvgkMWxHXtzXKKWBdGqalnUUy1_wqrapGp2keDXM84mlABCvTpWHHvG8pvM-D2EDjxAeEdEnpDAo4QZMYkBt0kiN5fNnKQixAvOJ6diMuUfLrPLO5qcPzP4NH2jbV3N_Rc9JDZSrbOH6BGVJI_lW-Pi4u5_ioDYoVFXo1ySJGWctVnJf70knkW27p1FDWV_D2f2qyR_O3aON1f6RXXDVhirTa6Hy4UZ2h9_czneY0ZP0EaLPvF45S5P0QNfbqH1ohN920ZX59XN7Ju2GsAnbumdagwgEY9tJ4SGq9C0nH48P2P4fRnAqeY6DoYLvay9w-Y7jvUj-N2qHh7PSjyZfj4q6h00PT76VEySVoIh0VyKRZIHY6XMpdFUU5oHCjaXxDBiabCZyZgBxEI0c05T4bxlYN9gpPMBoF3OA3uG1sqq9LsI09QDmrPGiUxyznweiDY2uFT4TEurB-gQFka1W6hWTXacpqpbLdWu1gC97oymblaMHP_p-zZa9Ve_yKXdNIA5VLs1lXNMyhAkdVzwEXwli9eHR6nNUpggIQP0qvMJBdaICRVd-mpZK4BGMa0MIdkAyZ6z9EbsPylnXxsWb8kheKSjvXtOex89pjHUj-oV2XO0trhd-heAhxbmZbMRfgLkbgb8
  priority: 102
  providerName: American Chemical Society
– databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hXsqlagsVKQ8tEhw4mKz3GR9LlBIQVFVFUE6s9llyiB3hpFL_PbN-VPGlXLiuV_Lqm5H2-zzjbxB6F4DCeyKLjESeRpgRm1lImyx5cznhFZUx_eD8_UrOF_zrUiz3Rn2lnrDWHrgFbuw9UypGRT2XfJIH4BtMTCa5E7kVjLRqPd8XU83XFQlKgvZ1SbjHxsbV1Trcmo_EJcf25BIIS4PbqDHtHzDNYZ_k3sVzeYyOOsaIL9qTnqAnoTxFh9N-UNsz9Oum2qzujAONH3BnyVRjIHb4wvXDy3AVm5WrbzfXDH8pIyTC2qSz4qnZ1cFje49Tzwf-3Paw41WJ54ufs2n9HC0uZz-m86wbm5AZruQ2K6J1ShXKGmooLSKFOCliGXE0OgGgWWAZxDDvDZU-OAYxiVb5EIGOFTyyM3RQVmV4gTAFvEXurJdCcc5CEYmxLvpcBmGUMyP0HkDUXdrXuqlo01z3YOsO7BH60MOsN62LxiN7P6U4POxL_tfNAmSF7rJC_ysrRuhtH0UN0UhFEFOGaldroDOpFAwyaoTUILyDNw6flKvfjfO24iD46OT8fxzxJXpKk3ZP4yjEK3Sw_bMLr4HgbO2bJpf_AtzD-Xo
  priority: 102
  providerName: Directory of Open Access Journals
Title Ropivacaine Prevents the Activation of the NLRP3 Inflammasome Caused by High Glucose in HUVECs
URI http://dx.doi.org/10.1021/acsomega.0c03143
https://search.proquest.com/docview/2444605974
https://pubmed.ncbi.nlm.nih.gov/PMC7496028
https://doaj.org/article/dd377ff72d46481e93235881c51b5300
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwFLamc4ELYhVlqYwEBw5pHa_NcYhmKIipRgNFcyLyOlSiSTVpkbjw23l2EzS5cOCSg-0oznuf5O_5bQi99kDhHZFFRgKPLcyIyQzAJou1uaxwisoQE5zPl3Kx4h-vxNUREn0uTArat2Y9rX9spvX6e4qt3G7srI8Tm12cl4oD76bz2QiNFGO3TPR0sSLBiKC9SxKOsJm2bbPx13pKbCzWHlvnsOjeymOn4hHMDs6kVLp_wDeH0ZK3jp-z--hexxvxyWF_D9CRrx-iO2Xfru0R-nbZbNc_tQVL3-OuMFOLgd7hE9u3MMNNSCPLT5cXDH-oA8Bho-O2can3rXfY_MIx8gO_P0Sy43WNF6uvp2X7GK3OTr-Ui6xrnpBpruQuK4KxShXKaKopLQIFbSliGLE0WGEEM8A1iGbOaSqdtww0E4xyPgApK3hgT9Bx3dT-KcI098DDrHFSKM6ZLwLRxgaXSy-0snqM3oAQqw78bZX82jSverlXndzH6G0v5mp7qKXxj7Xvoh7-rotVsNNAc3NddVionGNKhaCo45LPYZcsJv7Ocyty-EFCxuhVr8UKtBFdIbr2zb6tgNREhzAYU2OkBuodfHE4A3BM9bc7-D377zefo7s0mu2xE4V4gY53N3v_ErjNzkyA25efJ-lmAJ7L39NJQvcfL67-ZA
link.rule.ids 230,315,733,786,790,870,891,2113,2778,27098,27102,27946,27947,53816,53818,57082,57106,57132,57156
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxEB6VcigX3qgpLyPBgcMGr-1dZ48lakkhjVBoUE9YfkKEult1EyT49Yw3uy2LEIKrbfk1Y81nz_gbgOceIbyjeZHQIGIKM2oSg2qTRG4umznJ8hA_OB_P8slCvD3NTrcg7f7C4CRq7KlunPhX7ALpKyyrzvxnPaQ2Mq7za3A9k2i_Ihoaf7h6VsnxCtEkWWNC0iTlgrfOyT91Ek2SrXsmqWHu78HNfrDkL9bn8BbML-fdBJ18Ha5XZmh__Ebp-F8Luw03WyxK9jfKcwe2fHkXdsZdCrh78GlenS-_aasRipKW7KkmCBnJvu3SopEqNCWz6fw9J0dlQBU703EwMtbr2jtivpMYTULebKLjybIkk8XHg3F9HxaHByfjSdImZEi0kPkqKYKxUhbSaKYZKwJDDZDUcGpZsJnJuEH8QjV3TrPcectR2sFI5wMCvUIE_gC2y6r0u0BY6hHbWePyTArBfRGoNja4NPeZllYP4AVujGoPVK0aXzlLVbdbqt2tAbzsZKfON_wcf2n7Ogr3sl1k1m4KUCSqPajKOS5lCJI5kYsRzpLHz8Sj1GYpLpDSATzrVEOhNKJ7RZe-WtcKgVJ0MuMFbQCypzO9Efs15fJLw-ktBV4l2WjvH5f9FHYmJ8dTNT2avXsIN1h8BIh5LbJHsL26WPvHiJRW5klzNn4Cf0IPXg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VIgEXVF5igYKR4MAhxfEj3hzbpcsWyqqqWNQTlp-whyYrsovUC7-dcTYBIiHE1Ykce76x_E3G_gbgRUAK72lRZjSKVMKM2syi22RJm8tJr1gR0wXnD_NithDvLuTFDsj-LgwOosGemjaJn1b1ysdOYSB_je31ZfhiDqhLquv8GlyXCgOQVO_yx8HvXysFhhFtoTUmFM1yLniXoPxbJ2lbcs1gW2rV-weUc3hg8o8daLoHtzvqSA63WN-BnVDdhZuTvmLbPfh8Xq-W343DYD-QTpupIcjwyKHrq5iROrYt89PzM05OqogecWnSWMnEbJrgib0i6fAHebs9zE6WFZktPh1PmvuwmB5_nMyyrn5CZoQq1lkZrVOqVNYww1gZGQKmqOXUseikldwi3aCGe29Y4YPjCE60yoeIvKwUkT-A3aquwkMgLA9IxZz1hVRC8FBGaqyLPi-CNMqZEbxEI-rO_xvdprZZrntj687YI3jVm1mvtnIa_3j3KOHw670khN02oGvobl1p77lSMSrmRSHGOEqe7v6OcydznCClI3jeo6gRjZQNMVWoN41GXpNywhhPjUAN4B18cfikWn5tJbiVwMiPjR_957SfwY2zN1N9ejJ__xhusRSypyoU8gnsrr9twj7ymrV92nrxTz5X9I0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ropivacaine+Prevents+the+Activation+of+the+NLRP3+Inflammasome+Caused+by+High+Glucose+in+HUVECs&rft.jtitle=ACS+omega&rft.au=Huang%2C+Xin&rft.au=Jiang%2C+Jingyan&rft.au=Huang%2C+Lijun&rft.au=Ren%2C+Qiusheng&rft.date=2020-09-15&rft.pub=American+Chemical+Society&rft.issn=2470-1343&rft.eissn=2470-1343&rft.volume=5&rft.issue=36&rft.spage=23413&rft.epage=23419&rft_id=info:doi/10.1021%2Facsomega.0c03143&rft.externalDocID=h48175788
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2470-1343&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2470-1343&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2470-1343&client=summon